VACBF (Nykode Therapeutics AS) Total Liabilities : $25.77 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Nykode Therapeutics AS Total Liabilities?

Nykode Therapeutics AS's Total Liabilities for the quarter that ended in Sep. 2024 was $25.77 Mil.

Nykode Therapeutics AS's quarterly Total Liabilities declined from Mar. 2024 ($33.17 Mil) to Jun. 2024 ($27.80 Mil) and declined from Jun. 2024 ($27.80 Mil) to Sep. 2024 ($25.77 Mil).

Nykode Therapeutics AS's annual Total Liabilities declined from Dec. 2021 ($71.50 Mil) to Dec. 2022 ($64.46 Mil) and declined from Dec. 2022 ($64.46 Mil) to Dec. 2023 ($36.93 Mil).

Nykode Therapeutics AS Total Liabilities Historical Data

The historical data trend for Nykode Therapeutics AS's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nykode Therapeutics AS Total Liabilities Chart

Nykode Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

5.76

51.18

71.50

64.46

36.93

Nykode Therapeutics AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Liabilities	Get a 7-Day Free Trial															44.17	36.93	33.17	27.80	25.77

Nykode Therapeutics AS Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Nykode Therapeutics AS's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	20.608	+	(4.269	+	12.049
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	36.93

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	208.185	-	171.259
	=	36.93

Nykode Therapeutics AS's Total Liabilities for the quarter that ended in Sep. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16.172	+	(3.125	+	6.477
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	25.77

Total Liabilities	=	Total Assets (Q: Sep. 2024 )	-	Total Equity (Q: Sep. 2024 )
	=	168.413	-	142.639
	=	25.77

Nykode Therapeutics AS Total Liabilities Related Terms

Thank you for viewing the detailed overview of Nykode Therapeutics AS's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Nykode Therapeutics AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nykode Therapeutics AS (OTCPK:VACBF) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

NYKD:Norway 5VB:Germany

Address

Gaustadalleen 21, Oslo Research Park, Oslo, NOR, 0349

Website

https://www.nykode.com

Nykode Therapeutics AS is a clinical-stage biopharmaceutical company focused on the discovery and development of novel immunotherapies. The company is developing individualized cancer neoantigen vaccines and is using the Vaccibody technology to generate therapeutics to treat cancers with a high unmet medical need.